Most lately, it has been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in comparable locations as classical opioid receptors, it binds to some wide array of endogenous opioids. Not like most opioid receptors, this receptor acts like a scavenger https://pauly197svw8.wikiconverse.com/user